Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/116907) titled 'Efficacy of Kutajastak avaleha drug in heavy menstrual bleeding' on Sept. 2.
Study Type: Interventional
Study Design:
Randomized, Parallel Group Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Case Record Numbers Blinding and masking:Participant Blinded
Primary Sponsor: PMT Ayurved College and Shri eknath rugnalaya
Condition:
Health Condition 1: N920- Excessive and frequent menstruation with regular cycle
Recruitment Status: Not Recruiting
Phase: Phase 2/ Phase 3
Date of First Enrollment: 14-09-2026
Target Sample Size: 64
Co...